The study demonstrated that HAS1 type HA-synthase is expressed in BC cells and the expression is upregulated, both at the transcriptional and translational levels, suggesting that HAS1 expression may have prognostic potential related to tumor recurrence and progression. The gene discussed is HAS1; the disease is breast cancer.